
Sign up to save your podcasts
Or
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
4.7
1919 ratings
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
291 Listeners
314 Listeners
48 Listeners
861 Listeners
492 Listeners
14 Listeners
90 Listeners
25 Listeners
513 Listeners
132 Listeners
349 Listeners
183 Listeners
365 Listeners
5 Listeners
79 Listeners